INS and type 2 diabetes mellitus: LCKD therapy demonstrated significant improvements in lipid profile, fasting serum glucose and insulin levels, liver function, metabolic health, C-reactive protein levels and some inflammatory markers and medication use, predominantly in patients with T2D [83,84,85,86,87].